MRSGX
Price
$22.45
Change
-$0.21 (-0.93%)
Updated
Sep 20 closing price
VTSNX
Price
$135.52
Change
-$1.58 (-1.15%)
Updated
Sep 20 closing price
Ad is loading...

MRSGX vs VTSNX

Header iconMRSGX vs VTSNX Comparison
Open Charts MRSGX vs VTSNXBanner chart's image
MFS Research International R1
Price$22.45
Change-$0.21 (-0.93%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$135.52
Change-$1.58 (-1.15%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MRSGX vs VTSNX Comparison Chart
Loading...
VS
MRSGX vs. VTSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSGX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 453B vs. MRSGX (17B). VTSNX pays higher dividends than MRSGX: VTSNX (3.29) vs MRSGX (0.00). MRSGX was incepted earlier than VTSNX: MRSGX (19 years) vs VTSNX (14 years). MRSGX is a more actively managed with annual turnover of: 16.00 vs. VTSNX (4.00). MRSGX has a lower initial minimum investment than VTSNX: MRSGX (0) vs VTSNX (5000000). VTSNX (18.02) and MRSGX (17.85) have marching annual gain over last year. MRSGX return over 5 years is better than : 36.84 vs. VTSNX (25.80).
MRSGXVTSNXMRSGX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years14 years-
Gain YTD10.2659.653106%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets17B453B4%
Annual Yield % from dividends0.003.29-
Returns for 1 year17.8518.0299%
Returns for 3 years2.321.06218%
Returns for 5 years36.8425.80143%
Returns for 10 years53.5532.68164%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FKWL4.400.36
+8.91%
Franklin Wireless Corp
EPIX6.630.15
+2.31%
ESSA Pharma
BILI15.900.12
+0.76%
Bilibili
LYG3.110.01
+0.32%
Lloyds Banking Group PLC
INVA19.36-0.31
-1.58%
Innoviva